Ahn-Horst R, Turner E, Kesselheim A
JAMA Netw Open. 2025; 8(1):e2456588.
PMID: 39869338
PMC: 11774090.
DOI: 10.1001/jamanetworkopen.2024.56588.
Nakamura T, Yoshihara T, Tanegashima C, Kadota M, Kobayashi Y, Honda K
Mol Psychiatry. 2024; 29(9):2888-2904.
PMID: 38528071
PMC: 11420081.
DOI: 10.1038/s41380-024-02479-8.
Cain C
Curr Top Behav Neurosci. 2023; 64:19-57.
PMID: 37532965
PMC: 10840073.
DOI: 10.1007/7854_2023_434.
Spriggs M, Murphy-Beiner A, Murphy R, Bornemann J, Thurgur H, Schlag A
Front Psychol. 2023; 14:1119115.
PMID: 37251069
PMC: 10211333.
DOI: 10.3389/fpsyg.2023.1119115.
Kim Y, Kim S
Psychiatry Investig. 2023; 20(6):504-514.
PMID: 37248690
PMC: 10307917.
DOI: 10.30773/pi.2022.0343.
Perceived risk of LSD varies with age and race: evidence from 2019 United States cross-sectional data.
Bormann N, Weber A, Miskle B, Woodson-DeFauw N, Arndt S, Lynch A
Soc Psychiatry Psychiatr Epidemiol. 2023; 58(10):1503-1508.
PMID: 36879096
DOI: 10.1007/s00127-023-02448-6.
A paradigm shift in translational psychiatry through rodent neuroethology.
Shemesh Y, Chen A
Mol Psychiatry. 2023; 28(3):993-1003.
PMID: 36635579
PMC: 10005947.
DOI: 10.1038/s41380-022-01913-z.
Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies.
Miller A, Raison C
Mol Psychiatry. 2022; 28(1):68-75.
PMID: 36460725
DOI: 10.1038/s41380-022-01887-y.
"The wrong tools for the right job": a critical meta-analysis of traditional tests to assess behavioural impacts of maternal separation.
Stupart O, Robbins T, Dalley J
Psychopharmacology (Berl). 2022; 240(11):2239-2256.
PMID: 36418564
PMC: 10593619.
DOI: 10.1007/s00213-022-06275-6.
Proof-of-Mechanism Study of the Phosphodiesterase 10 Inhibitor RG7203 in Patients With Schizophrenia and Negative Symptoms.
Umbricht D, Abt M, Tamburri P, Chatham C, Holiga S, Frank M
Biol Psychiatry Glob Open Sci. 2022; 1(1):70-77.
PMID: 36324430
PMC: 9616307.
DOI: 10.1016/j.bpsgos.2021.03.001.
Drug Discovery in Psychiatry: Rethinking Conventional Wisdom.
Ghaemi S
Can J Psychiatry. 2022; 68(2):81-85.
PMID: 35837715
PMC: 9923139.
DOI: 10.1177/07067437221112907.
Putting the "mental" back in "mental disorders": a perspective from research on fear and anxiety.
Taschereau-Dumouchel V, Michel M, Lau H, Hofmann S, LeDoux J
Mol Psychiatry. 2022; 27(3):1322-1330.
PMID: 35079126
PMC: 9095479.
DOI: 10.1038/s41380-021-01395-5.
As soon as there was life, there was danger: the deep history of survival behaviours and the shallower history of consciousness.
LeDoux J
Philos Trans R Soc Lond B Biol Sci. 2021; 377(1844):20210292.
PMID: 34957848
PMC: 8710881.
DOI: 10.1098/rstb.2021.0292.
Translational opportunities in animal and human models to study alcohol use disorder.
Nieto S, Grodin E, Aguirre C, Izquierdo A, Ray L
Transl Psychiatry. 2021; 11(1):496.
PMID: 34588417
PMC: 8481537.
DOI: 10.1038/s41398-021-01615-0.
Characteristic and Early Discontinuation of Obsessive-Compulsive Disorder Trials Registered on ClinicalTrials.gov.
Luo S, Guo Q, Yang L, Cheng Y, Long Y, Wang X
Front Psychiatry. 2021; 12:650057.
PMID: 34381385
PMC: 8350037.
DOI: 10.3389/fpsyt.2021.650057.
Intranasal esketamine and the dawn of precision psychiatry.
Watts D, Garcia F, Lacerda A, Mari J, Quarantini L, Kapczinski F
Braz J Psychiatry. 2021; 44(2):117-118.
PMID: 34320126
PMC: 9041972.
DOI: 10.1590/1516-4446-2021-0031.
Moving Toward a Human Rights Approach to Mental Health.
Probert J
Community Ment Health J. 2021; 57(8):1414-1426.
PMID: 33934236
PMC: 8088315.
DOI: 10.1007/s10597-021-00830-9.
Trends in US pediatric mental health clinical trials: An analysis of ClinicalTrials.gov from 2007-2018.
Wortzel J, Turner B, Weeks B, Fragassi C, Ramos V, Truong T
PLoS One. 2021; 16(4):e0248898.
PMID: 33793587
PMC: 8016324.
DOI: 10.1371/journal.pone.0248898.
Searching for Imaging Biomarkers of Psychotic Dysconnectivity.
Rodrigue A, Mastrovito D, Esteban O, Durnez J, Koenis M, Janssen R
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021; 6(12):1135-1144.
PMID: 33622655
PMC: 8206251.
DOI: 10.1016/j.bpsc.2020.12.002.
Deep Learning-Based Human Activity Recognition for Continuous Activity and Gesture Monitoring for Schizophrenia Patients With Negative Symptoms.
Umbricht D, Cheng W, Lipsmeier F, Bamdadian A, Lindemann M
Front Psychiatry. 2020; 11:574375.
PMID: 33192706
PMC: 7525025.
DOI: 10.3389/fpsyt.2020.574375.
